Electronic Commerce Partnership Agreement between ProxyMed and Eclipsys Corporation

Strategic Insights -

ProxyMed, Inc. and Eclipsys Corporation have entered into a significant partnership that will revolutionize the healthcare industry. This Electronic Commerce Partnership Agreement allows Eclipsys to integrate ProxyMed's value-added drug formularies and network access capabilities into its clinical management suite, further enhancing its Sunrise software product line. The integration is expected to provide Eclipsys' clients with seamless access to managed-care organization formularies, electronic prescription order entry, and refill request authorization capabilities via ProxyMed's secure national network, ProxyNet.

Key Takeaways:

  • The partnership between ProxyMed and Eclipsys Corporation aims to provide Eclipsys' clients with comprehensive and integrated healthcare information systems.
  • The integrated clinical management suite will offer access to managed-care organization formularies, electronic prescription order entry, and refill request authorization capabilities.
  • Eclipsys' clients include over 300 of the largest and most prestigious hospitals, medical centers, and integrated health networks.
  • The integration is expected to enhance Eclipsys' clients' ability to improve results in five key areas: cost reduction and control, quality improvement, service improvement, business strategy, and physician integration.
  • ProxyMed's proximity to customers and Eclipsys' vast customer base will significantly expand the reach of both companies.

Statistics:

  • Eclipsys has over 300 clients, including the largest and most prestigious hospitals, medical centers, and integrated health networks.
  • ProxyMed's partnership with Eclipsys adds 300 prospective customers, providing access to formularies from managed-care organizations, including CIGNA Health Plans, Humana, PacifiCare, and others.
  • The integrated clinical management suite is expected to enhance Eclipsys' clients' ability to improve results in five key areas.

Sources:

  • PRNewswire
  • ONLINE VERSION OF THE ORIGINAL NEWS RELEASE
  • SOURCE

ProxyMed, Inc. /CONTACT: Investor Relations: Cheryl Schneider, Stacey Levitz, Press: David Sassoon of Morgen-Walke Associates, Inc., 212-850-5600, for ProxyMed, Inc./ (PILL) CO: ProxyMed, Inc.; Eclipsys Corporation ST: Florida IN: MTC SU: SH -- NYTU124 -- 4070 01/06/98 13:01 EST

  • http://www.eclipsys.com
  • http://www.proxymed.com